New device to improve intravenous therapy safety

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study focuses on validating a novel fixative device designed to enhance the safety and effectiveness of intravenous therapies. A multidisciplinary team has collaborated to create this device, which aims to reduce complications associated with vascular access and catheter use. The device allows for better control and identification of the pharmacological therapies administered to patients, potentially minimizing risks such as catheter malfunction and infection.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* patients admitted to the intensive care unit
* patients with authorization to take part in the study

Exclusion Criteria:

* Patients with pre-existing medical conditions: Patients with diseases affecting coagulation, such as hemophilia or thrombocytopathies, could be excluded.
* Active infection patients: Any patient with vascular access site infections or systemic infections may be excluded to avoid complications.
* Inability to give informed consent: Patients who are unable to understand or consent to participate in the study.

Where it's running

• Hospital Universitario de Navarra
  Pamplona, Navarre, Spain Recruiting

Study contacts

• Principal investigator: Marta M Ferraz-Torres, PHD — Fundación Miguel Servet
• Study coordinator: marta M FERRAZ-TORRES, PHD
• Email: marta.ferraz.torres@navarra.es
• Phone: +34628813974

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Single-needle distal return for long-term AV fistula care

  This trial tests a single-needle method that draws blood from your arm fistula and returns it through a foot or lower-leg vein to see if it reduces damage and the need for repeat procedures in adults on thrice-weekly hemodialysis.

  Recruiting Suzhou Municipal Hospital of Anhui Province · Suzhou, Anhui · NCT07372027

• Innovative Tube Trabeculectomy for Advanced and Refractory Glaucoma

  A randomized trial tests a new surgical method called ITT against standard trabeculectomy to see if it better lowers eye pressure with fewer medications and complications in adults with advanced or treatment-resistant glaucoma.

  Recruiting Benha University · Banhā · NCT07755761

• Radial and Ulnar Access in Vascular Interventions Registry

  This registry tests how often radial or ulnar artery access is used and what happens afterward in routine vascular procedures.

  Recruiting Mersin Medicalpark Hastanesi · Mersin, Mezitli · NCT07614386

• Using the ulnar artery when the same-arm radial artery is blocked for heart angiography or angioplasty

  This study will try using the ulnar artery in the same arm with a blocked radial artery to see if it's safe and how it affects hand strength, feeling, and everyday hand use in adults having coronary angiography or angioplasty.

  Recruiting at 2 sites National and Kapodistrian University of Athens · Athens and 1 other locations · NCT07380399

• Immersive VR hypnosis to reduce anxiety in nurses

  This pilot will try short hypnotic immersive VR sessions to see if they reduce anxiety in day-shift nurses during their coffee break.

  Recruiting SCP Anesthésie - Réanimation de la Clinique du Pont de Chaume · Montauban · NCT07293221

• Irrisept to reduce urinary tract infections when a urethral catheter is removed

  This study tests whether rinsing the bladder with Irrisept (0.05% chlorhexidine) instead of saline at the time of catheter removal reduces UTIs in adults having their urethral catheter removed.

  Recruiting Ohio State University · Columbus, Ohio · NCT07239219

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.